Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 139.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 147.00
  • 52 Week Low: 93.50
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 38,624
  • Market Cap: £117.84m
  • RiskGrade: 196
  • Beta: 0.00

Other News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 139.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 147.00
52 Week Low 93.50
Volume 38,624
Shares Issued 84.77m
Market Cap £117.84m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38% below the market average38% below the market average38% below the market average38% below the market average38% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
81.70% above the market average81.70% above the market average81.70% above the market average81.70% above the market average81.70% above the market average
94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average
Income Not Available
Growth
22.50% above the market average22.50% above the market average22.50% above the market average22.50% above the market average22.50% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 14-Feb-2025

Time Volume / Share Price
16:39 30,000 @ 139.00p
15:40 100 @ 138.90p
15:34 6,000 @ 138.00p
14:59 24 @ 139.00p
08:56 2,500 @ 138.12p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page